Enoblituzumab, previously known as TJ-271 or MGA271, represents a unique monoclonal directed at CD33, an surface protein found predominantly on myeloid tissues. The antibody works as the bispecific construct, at once https://rebeccagmbg819612.mpeblog.com/74719090/enoblituzumab-a-deep-dive-into-tj-271-and-mga271